Beijing Leadman BiochemistryLtd Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	3yrs

Son yönetim güncellemeleri

Recent updates

Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

Oct 08

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Apr 19

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Mar 08

CEO

Beijing Leadman BiochemistryLtd CEO'su yok ya da onlar hakkında elimizde veri yok.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yan Wang	Independent Director	5.8yrs	CN¥120.00k	0.26% CN¥ 6.9m
Yuqing Ouyang	Member of Supervisory Board	5.8yrs	Veri yok	Veri yok
Kaixiang Wang	Non-Independent Chairman of the Board	4.3yrs	Veri yok	Veri yok
Yunxin Zheng	Non-Independent Director	3yrs	Veri yok	Veri yok
Zhenghe Yang	Non-Independent Director	3.7yrs	Veri yok	Veri yok
Yanyi Huang	Non-Independent Director	3yrs	CN¥180.00k	Veri yok
Zhiqian Zhang	Independent Director	3yrs	CN¥120.00k	Veri yok
Na An	Independent Director	3yrs	CN¥120.00k	Veri yok
Guan Yu Lin	Chairman of the Supervisory Board	3yrs	Veri yok	Veri yok

3.0yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300289 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3 yıldır).

Beijing Leadman BiochemistryLtd Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 29, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 12, 2022

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.001 (vs CN¥0.013 in 3Q 2023)

Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

Beijing Leadman Biochemistry Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Second quarter 2024 earnings released: EPS: CN¥0.006 (vs CN¥0.015 in 2Q 2023)

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2024 Results on Aug 17, 2024

First quarter 2024 earnings released: CN¥0.005 loss per share (vs CN¥0.015 profit in 1Q 2023)

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Now 20% undervalued after recent price drop

Beijing Leadman Biochemistry Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 29, 2024

Full year 2023 earnings released: EPS: CN¥0.03 (vs CN¥0.10 loss in FY 2022)

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Now 21% undervalued after recent price drop

Beijing Leadman Biochemistry Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 28, 2024

Third quarter 2023 earnings released: EPS: CN¥0.013 (vs CN¥0.019 in 3Q 2022)

Beijing Leadman Biochemistry Co.,Ltd. to Report Q3, 2023 Results on Oct 24, 2023

Second quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.022 in 2Q 2022)

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023

Full year 2022 earnings released: CN¥0.10 loss per share (vs CN¥0.05 profit in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.019 (vs CN¥0.034 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.022 (vs CN¥0.018 in 2Q 2021)

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS: CN¥0.022 (vs CN¥0.015 in 1Q 2021)

High number of new and inexperienced directors

Beijing Leadman Biochemistry Co.,Ltd. Approves Cash Dividend for the Year 2021

Beijing Leadman Biochemistry Co.,Ltd., Annual General Meeting, Apr 12, 2022

High number of new and inexperienced directors

Third quarter 2021 earnings released: EPS CN¥0.034 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.018 (vs CN¥0.023 in 2Q 2020)

Full year 2020 earnings released: CN¥0.12 loss per share (vs CN¥0.016 profit in FY 2019)

Beijing Leadman Biochemistry Co.,Ltd. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥8.19

New 90-day low: CN¥5.86

Beijing Leadman Biochemistry Co.,Ltd. Announces Dismissal of Luo Haobo as a Director

New 90-day low: CN¥6.46

New 90-day low: CN¥6.59

New 90-day high: CN¥8.14

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) signed a share transfer agreement to acquire Shanghai Shangtuo Industrial Co., Ltd. from Shanghai Kelian Commercial Services Center and Wu Fanglin.

New 90-day high - CN¥7.90

Earnings released

Beijing Leadman Biochemistry Co.,Ltd. to Report First Half, 2020 Results on Aug 15, 2020

CEO

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş